Psyence Group Inc. 13D/13G Filings for Psyence Biomedical Ltd. (PBM)

Psyence Group Inc. 13D and 13G filings for Psyence Biomedical Ltd.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-05
4:30 pm
Purchase
2024-01-2513DPsyence Biomedical Ltd.
PBM
Psyence Group Inc.8,333
37.340%
8,333increase
(New Position)
Filing